Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Gengyin Zhou"'
Autor:
Yunxiang Zhang, Kai Han, Xiaotong Dong, Qian Hou, Tianbao Li, Li Li, Gengyin Zhou, Xia Liu, Guifeng Zhao, Wei Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Nuclear protein of the testis (NUT) carcinoma is a very rare and aggressive carcinoma characterized by chromosomal rearrangement. NUT-midline carcinoma (NMC) can occur anywhere in the body, but most of the tumors are found in the midline anatomic str
Externí odkaz:
https://doaj.org/article/42764424a2c14ac590b843fb9ecfb39b
Autor:
Jing Hu, Feifei Sun, Weiwen Chen, Jing Zhang, Tao Zhang, Mei Qi, Tingting Feng, Hui Liu, Xinjun Li, Yuanxin Xing, Xueting Xiong, Benkang Shi, Gengyin Zhou, Bo Han
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Abstract Background Cancer stem-like traits contribute to prostate cancer (PCa) progression and metastasis. Deciphering the novel molecular mechanisms underlying stem-like traits may provide important insight for developing novel therapeutics. Method
Externí odkaz:
https://doaj.org/article/5dd2020f0e144a79bf9eb2a7ae3bc128
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Multidrug resistance (MDR) is the major obstruction in the successful treatment of breast cancer (BCa). The elucidation of molecular events that confer chemoresistance of BCa is of major therapeutic importance. Several studies have elucidated the cor
Externí odkaz:
https://doaj.org/article/2ac8b2f997c74f758d58faed0794e5b6
Autor:
Jing Hu, Peng Su, Meng Jiao, Xinnuo Bai, Mei Qi, Hui Liu, Zhen Wu, Jingtian Sun, Gengyin Zhou, Bo Han
Publikováno v:
Translational Oncology, Vol 11, Iss 2, Pp 416-425 (2018)
Breast cancer (BC) is among the most common malignant diseases and metastasis is the handcuff of treatment. Cancer metastasis is a multistep process associated with the epithelial-mesenchymal transition (EMT) program. Several studies have demonstrate
Externí odkaz:
https://doaj.org/article/4e89981ab74a416e8e35b416c5aca151
Autor:
Xiaojuan Wu, Xiaofang Zhang, Limin Sun, Hui Zhang, Li Li, Xiao Wang, Weiwei Li, Peng Su, Jing Hu, Peng Gao, Gengyin Zhou
Publikováno v:
Cellular Physiology and Biochemistry, Vol 32, Iss 2, Pp 344-354 (2013)
Background/Aims: Breast cancer resistance protein (BCRP) plays a crucial role in multidrug resistance (MDR). Previous studies have shown that steroid hormones, like progesterone (PROG), regulate BCRP expression. The presence of a progesterone respons
Externí odkaz:
https://doaj.org/article/a4d31862c6c04d16ba96660db0b9c42e
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118026 (2015)
The purpose of this work was to analyze the relationships between the expression status of Lysosomal-associated protein transmembrane-4 beta 35 (LAPTM4B-35) in cancerous tissues and clinicopathological characteristics and prognosis of the patients wi
Externí odkaz:
https://doaj.org/article/938a62e8fcd84c1eb40ac0ca91753f13
Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer.
Autor:
Xiaofang Zhang, Xiaojuan Wu, Peng Su, Yongsheng Gao, Bin Meng, Yanlin Sun, Li Li, Zhiqiang Zhou, Gengyin Zhou
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48492 (2012)
INTRODUCTION: Glucosylceramide synthase (GCS) is one enzyme that provides a major route for ceramide clearance. Recent evidence has indicated an important role for GCS in multidrug resistance (MDR) tumors. Doxorubicin (DOX)can modulate the expression
Externí odkaz:
https://doaj.org/article/eb9e9463fc144277b45394121cfacfe9
Autor:
Gengyin Zhou, Li Li, Liu Xia, Tianbao Li, Qian Hou, Kai Han, Xiaotong Dong, Wei Li, Guifeng Zhao, Yunxiang Zhang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Nuclear protein of the testis (NUT) carcinoma is a very rare and aggressive carcinoma characterized by chromosomal rearrangement. NUT-midline carcinoma (NMC) can occur anywhere in the body, but most of the tumors are found in the midline anatomic str
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Multidrug resistance (MDR) is the major obstruction in the successful treatment of breast cancer (BCa). The elucidation of molecular events that confer chemoresistance of BCa is of major therapeutic importance. Several studies have elucidated the cor
Autor:
Hui Liu, Zhen Wu, Jingtian Sun, Meng Jiao, Bo Han, Peng Su, Xinnuo Bai, Jing Hu, Mei Qi, Gengyin Zhou
Publikováno v:
Translational Oncology
Translational Oncology, Vol 11, Iss 2, Pp 416-425 (2018)
Translational Oncology, Vol 11, Iss 2, Pp 416-425 (2018)
Breast cancer (BC) is among the most common malignant diseases and metastasis is the handcuff of treatment. Cancer metastasis is a multistep process associated with the epithelial-mesenchymal transition (EMT) program. Several studies have demonstrate